Inotiv Valuation
| NOTV Stock | USD 3.11 0.13 4.36% |
At this time, the firm appears to be undervalued. Inotiv Inc retains a regular Real Value of $4.12 per share. The prevalent price of the firm is $3.11. Our model calculates the value of Inotiv Inc from evaluating the firm fundamentals such as Return On Equity of -0.57, current valuation of 510.33 M, and Return On Asset of -0.0478 as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Inotiv's price fluctuation is very risky at this time. Calculation of the real value of Inotiv Inc is based on 3 months time horizon. Increasing Inotiv's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Inotiv stock is determined by what a typical buyer is willing to pay for full or partial control of Inotiv Inc. Since Inotiv is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Inotiv Stock. However, Inotiv's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.11 | Real 4.12 | Hype 3.04 | Naive 3.03 |
The intrinsic value of Inotiv's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Inotiv's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Inotiv Inc helps investors to forecast how Inotiv stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Inotiv more accurately as focusing exclusively on Inotiv's fundamentals will not take into account other important factors: Inotiv Total Value Analysis
Inotiv Inc is now anticipated to have valuation of 510.33 M with market capitalization of 100.93 M, debt of 15.31 M, and cash on hands of 21.24 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Inotiv fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
510.33 M | 100.93 M | 15.31 M | 21.24 M |
Inotiv Investor Information
About 27.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.6. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Inotiv Inc recorded a loss per share of 4.61. The entity had not issued any dividends in recent years. Based on the key indicators related to Inotiv's liquidity, profitability, solvency, and operating efficiency, Inotiv Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Inotiv Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Inotiv has an asset utilization ratio of 62.81 percent. This indicates that the Company is making $0.63 for each dollar of assets. An increasing asset utilization means that Inotiv Inc is more efficient with each dollar of assets it utilizes for everyday operations.Inotiv Ownership Allocation
Inotiv Inc has a total of 33.87 Million outstanding shares. Inotiv retains 11.14 (percent) of its outstanding shares held by insiders and 26.64 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Inotiv Profitability Analysis
The company reported the previous year's revenue of 490.74 M. Net Loss for the year was (108.89 M) with profit before overhead, payroll, taxes, and interest of 102.74 M.About Inotiv Valuation
Our relative valuation model uses a comparative analysis of Inotiv. We calculate exposure to Inotiv's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Inotiv's related companies.Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries and sells analytical instruments to the pharmaceutical development and contract research industries. Inotiv, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana. Inotiv operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 541 people.
Inotiv Growth Indicators
Investing in growth stocks can be very risky. If the company such as Inotiv does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 25.9 M |
Additional Tools for Inotiv Stock Analysis
When running Inotiv's price analysis, check to measure Inotiv's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inotiv is operating at the current time. Most of Inotiv's value examination focuses on studying past and present price action to predict the probability of Inotiv's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inotiv's price. Additionally, you may evaluate how the addition of Inotiv to your portfolios can decrease your overall portfolio volatility.